Tokyo, Aug. 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062500) titled 'A Review of the Current Status of Personalized Medicine for Lung Cancer in the AYA Population and Challenges in Improving Prognosis' on Aug. 7.
Study Type:
Observational
Primary Sponsor:
Institute - Niigata University Graduate School of Medical and Dental Sciences
Condition:
Condition - Locally Advanced or Advanced Non-Small Cell Lung Cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to clarify the current status of driver gene mutation frequencies and treatment outcomes among AYA (ages 15-39) lung cancer patients following the introductio...